Achilles Therapeutics plc
ACHL
$1.48
$0.010.68%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/27/2025
-
MarketBeat
3/20/2025
-
TipRanks Financial Blog
3/15/2025
-
MarketBeat
2/28/2025
-
MarketBeat
2/28/2025
-
Seeking Alpha - Healthcare
2/28/2025
-
The Fly
2/28/2025
-
GuruFocus
2/28/2025
-
Globe Newswire
2/13/2025
-
MarketBeat
2/1/2025
-
Ticker Report
1/17/2025
-
Ticker Report
1/6/2025
-
TipRanks Financial Blog
12/31/2024
-
Ticker Report
12/29/2024
-
Ticker Report
12/27/2024
-
TipRanks Financial Blog
12/26/2024
-
TipRanks Financial Blog
12/24/2024
-
Benzinga
12/24/2024
-
Seeking Alpha - Healthcare
12/24/2024
-
GuruFocus
12/24/2024
-
TipRanks Financial Blog
12/24/2024
-
The Fly
12/24/2024
-
Globe Newswire
12/12/2024
-
Ticker Report
11/30/2024
-
Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 14, 2024
Period Date
Monday, September 30, 2024
Next Filing
Beginning of April (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
44 20 8154 4600
Address
245 Hammersmith Road
London, W6 8PW
London, W6 8PW
Country
Year Founded
Business Description
Sector
Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The...
more
